Does gender parity exist in Fabry disease?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Why should one be concerned about possible neurologic involvement in female carriers for Fabry disease (FD)? Although males are preferentially and more severely involved, most female carriers demonstrate clinical involvement, especially neuropathic pain, albeit at a later age. As an X-linked disorder, males are expected to express the disorder, but similar involvement in females is not expected. As such, FD behaves in some ways more as a dominant than a recessive condition. As suspected by the poets throughout the ages, females are more complicated than males in terms of their genetic makeup. There are 1,098 genes on the X chromosome (vs only a few dozen genes on the Y chromosome), of which one copy is presumed to be inactivated.1 Recent evidence suggests that about 15% of genes on the X chromosome escape inactivation and 10% may have variable inactivation.2 Such variable inactivation could lead to a more complicated clinical spectrum in the X-linked disorders such as FD.
Recent biochemical and …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Brief Communications
White matter lesion severity in male and female patients with Fabry diseaseA. Fellgiebel, M. J. Müller, M. Mazanek et al.Neurology, August 22, 2005 -
Article
Determinants of white matter hyperintensity burden in patients with Fabry diseaseNatalia S. Rost, Lisa Cloonan, Allison S. Kanakis et al.Neurology, April 20, 2016 -
Article
Thromboembolic events in Fabry disease and the impact of factor V LeidenMalte Lenders, Nesrin Karabul, Thomas Duning et al.Neurology, February 06, 2015 -
Articles
Diagnostic utility of different MRI and MR angiography measures in Fabry diseaseA. Fellgiebel, I. Keller, D. Marin et al.Neurology, January 02, 2009